Cresud S.A.C.I.F. y A (CRESY)
Cresud S.A.C.I.F. y A R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CRESY R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Sep 2007 |
| Maximum | 0.00 | Sep 2007 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CRESY related companies
CRESY News
$CRESY is -5.1% down since open on unusual high volume and -4.8% down since close.
about 13 days ago by TradeBot
about 13 days ago by TradeBot
Cresud S.A.C.I.F. y A. Announces Results for Nine-month period of FY 2012 Ended March 31, 2012
May 14, 10:45PM PR Newswire
May 14, 10:45PM PR Newswire
Cresud S.A.C.I.F. y A. Announces Results for Six-Month Period of FY 2012 Ended December 31, 2011
Feb 13, 8:20PM PR Newswire
Feb 13, 8:20PM PR Newswire
sold rest of $CRESY...out..sold 12.95 from buy on 1/20 at 12.15...
about 126 days ago by CoachDave316
about 126 days ago by CoachDave316
sold 1/2 of $CRESY position 13.02 (bot 10/4/11 9.93 and 10/21/11 10.94)
about 126 days ago by CoachDave316
about 126 days ago by CoachDave316
Interesting charts RT @EconomicDisconnect New Post! EconomicDisconnect: Tuesday Charts http://stks.co/1xri $NXTM $ANSS $INTU $MWIV $CRESY
about 132 days ago by StockSage1
about 132 days ago by StockSage1
New Post! EconomicDisconnect: Tuesday Charts http://stks.co/1xmD $NXTM $ANSS $INTU $MWIV $CRESY
about 132 days ago by EconomicDisconnect
about 132 days ago by EconomicDisconnect
IRSA Inversiones y Representaciones Sociedad Anonima Announces 20-F Filing
Dec 28, 5:47PM PR Newswire
Dec 28, 5:47PM PR Newswire
$CRESY Looking for Aggie Laggers. Spec shot. 11.15. I like to play the warm seasons.
about 217 days ago by T_Edward
about 217 days ago by T_Edward
Cresud S.A.C.I.F. y A. Announces Results for Fiscal Year 2011 Ended June 30, 2011
Sep 09, 12:22AM PR Newswire
Sep 09, 12:22AM PR Newswire
IRSA Inversiones y Representaciones Sociedad Anonima Announces Results for Fiscal Year 2011 Ended June 30, 2011
Sep 09, 12:16AM PR Newswire
Sep 09, 12:16AM PR Newswire
@howardlindzon those looking for a somewhat direct bet on farmland, $CRESY is an interesting play
about 325 days ago by bondtrader83
about 325 days ago by bondtrader83
Welcome $CRESY to Stocktwits IR for claiming their ticker and listening in on @stocktwits from Brazil
about 325 days ago by howardlindzon
about 325 days ago by howardlindzon
Billionaire Soros Readies Agriculture IPO $MON $WFT,$IOC $KGC $NG $CRESY $POT http://stk.ly/gTA4F0
about 498 days ago by HistorySquared
about 498 days ago by HistorySquared
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CRESY | 7.79 | +0.19 | +2.50% | 390.75M |
| CREG | 1.11 | +0.00 | +0.00% | 48.32M |
| CREE | 26.11 | +0.20 | +0.77% | 3.031B |
| CPLP | 7.54 | +0.03 | +0.40% | 523.05M |
| CPLA | 31.27 | +0.64 | +2.09% | 425.58M |
| CPL | 23.94 | +0.17 | +0.72% | 11.52B |
| CPK | 42.22 | +0.05 | +0.12% | 404.47M |
| CPHI | 0.3499 | -0.00 | -0.03% | 15.23M |
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| DLB | 43.96 | -0.04 | -0.09% | 4.777B |
